Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,652 public trials 850 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies

NCT03922204

Conditions
Advanced Cancer, B-cell Lymphoma, Adult, Hemic and Lymphatic Diseases, +10 more
Locations
  • Moores Cancer Centre La Jolla, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospital Antwerp Antwerp, Edegem, Belgium
View Trial Details
Completed

Safety, PK/PD, and Clinical Activity of KT-413 in Adult Patients with Relapsed or Refractory B-cell NHL

NCT05233033

Conditions
DLBCL, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Participants With High-Risk Large B-Cell Lymphoma

NCT03761056

Conditions
B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Banner Health MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Completed

A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma

NCT03307746

Conditions
B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • The Christie NHS Foundation Trust Manchester, United Kingdom
  • Oxford University Hospitals NHS Foundation Trust Oxford, United Kingdom
  • Plymouth Hospitals NHS Trust Plymouth, United Kingdom
  • University Hospital Southampton NHS Foundation Trust Southampton, United Kingdom
View Trial Details
Completed

Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

NCT04930536

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma, Disease Attributes, +18 more
Locations
  • Research Site Ahmedabad, India
  • Research Site Bangalore, India
  • Research Site Bangalore, India
  • Research Site Bengaluru, India
View all 15 locations
View Trial Details
Completed

MB-CART20.1 Lymphoma

NCT03664635

Conditions
B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Disease Attributes, +15 more
Locations
  • University Hospital of Cologne - Clinic for Internal Medicine I Cologne, Germany
  • Universitätsklikum Leipzig, AöR Leipzig, Germany
View Trial Details

Related conditions